MediPal Holdings Corporation (TYO:7459)
Japan
· Delayed Price · Currency is JPY 2,651.50
-71.50 (-2.63%)
At close: Dec 5, 2025
MediPal Holdings Revenue
MediPal Holdings had revenue of 952.40B JPY in the quarter ending September 30, 2025, with 4.05% growth. This brings the company's revenue in the last twelve months to 3.74T, up 3.88% year-over-year. In the fiscal year ending March 31, 2025, MediPal Holdings had annual revenue of 3.67T with 3.16% growth.
Revenue (ttm)
3,744.22B
Revenue Growth
+3.88%
P/S Ratio
0.14
Revenue / Employee
286.67M
Employees
13,061
Market Cap
542.76B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 3,671.33B | 112.60B | 3.16% |
| Mar 31, 2024 | 3,558.73B | 198.72B | 5.91% |
| Mar 31, 2023 | 3,360.01B | 69.09B | 2.10% |
| Mar 31, 2022 | 3,290.92B | 79.80B | 2.48% |
| Mar 31, 2021 | 3,211.13B | -41.95B | -1.29% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,213.71B |
| HOYA Corporation | 892.50B |
| Takeda Pharmaceutical Company | 4,417.00B |
| Daiichi Sankyo Company | 1,978.88B |
| Otsuka Holdings | 2,418.53B |
| Astellas Pharma | 2,006.82B |
| Terumo | 1,062.42B |
| Shionogi & | 437.26B |